Inpatient Glycemic Management

Slides:



Advertisements
Similar presentations
Inpatient Hyperglycemia Management
Advertisements

Medications Insulin. Without Insulin With Treatment of Insulin.
In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.

Chris Harrold SpR Diabetes & Endocrinology.  Diabetes is common  15% of all inpatients  50% of those are on insulin  20% of patients experienced an.
MMI Task Force on Diabetes House Staff Curriculum.
Stepwise approach to inpatient diabetes management Erin Keely.
Diabetes (abridged!). Who needs screening for DM? Age >45 Obese – BMI >25 1 st degree relative with DM Racial groups: –African American –Hispanic American.
Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.
Part 1: Diabetes 101. Novo Nordisk: Changing Life with Diabetes  Food is broken down into glucose  Glucose = Sugar  Pancreas makes insulin and helps.
Putting Pump Policies Into Practice- Case Study Conference Call Elizabeth Blair, ANP-BC,CDE Joyce Lekarcyk, RN, CDE.
Management of Diabetes Mellitus in the Hospital
INPATIENT DIABETES GUIDE Ananda Nimalasuriya M.D..
Correction Insulin for Inpatient Hyperglycemia Estelle Lin June 2012.
MANAGEMENT OF HYPOGLYCEMIA A Nimalasuriya. INSULIN ACTIONS.
Insulin therapy.
Kathryn A. Hanavan ANP-BC; BC-ADM Harold Schnitzer Diabetes Health Center September 12,
Management of Inpatient Blood Glucose at Temple Housestaff Orientation 2014.
Diabetes Management in the Hospital: Case Studies Bruce W. Bode, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
Insulin Information The Basal-Bolus concept
Titrating Insulin to Glycemic Target Judy Bowen, MD CIM Rotation September, 2006.
Basal and Meal Time Insulin Case Study
MANAGEMENT OF THE HOSPITALIZED TYPE I DIABETIC PATIENT Riverside Methodist Hospital January 23, 2014 Rundsarah Tahboub, MD.
OnsetPeakDuration Rapid Acting Lispro (Humalog) min3-5 hours Aspart (Novolog)15-30 min1-3 hours3-5 hours Intermediate Acting NPH1-4 hours5-10.
Diabetes Update Division of Endocrinology Department of Medicine Wayne State University Medical School Detroit, Michigan Part 3 of 3.
Inpatient Diabetes Treatment Goals, Strategies, Safety Amish A. Dangodara, MD, FACP Professor of Medicine Internal Medicine, Hospitalist Program University.
1 Carb Counting and Insulin Administration Module Georgia Hospital Association Diabetes Special Interest Group.
K. Ann Caudell, PhD, ACNP - BC. * Identify patients with out-of-range CBGs * Assist in maintaining CBGs between 80 mg/dL & 180 mg/dL during hospitalization.
Module 41 Module 4 Pharmacologic Management of Hyperglycemia in the Hospital Part 1: Understanding How to Use Insulin Diabetes Special Interest Group Georgia.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 4.
Intensive Management of Inpatient Hyperglycemia Nicole L. Artz, MD
Insulin Glargine (Lantus) Lantus is a long-acting insulin that should be injected below the skin once daily as directed by your doctor. Take Lantus the.
Type I Diabetes Mellitus
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 2.
INSULIN PUMPS Shelby Polk DNP, FNP-BC, CDE. 2 MANAGEMENT OF DIABETES IN SCHOOLS Exercise Legal Rights Health & Learning Nutrition Insulin Administration.
50% Basal Total Daily Dose Split to mimic Euglycemic control 50% Bolus Establishing Starting Basal and Bolus Dosing Based on Pre-Meal Readings and Carb.
Insulins Roland Halil, BScPharm, ACPR, PharmD Clinical Pharmacist, Bruyere Academic Family Health Team Assistant Professor, Dept of Family Medicine, U.
Elizabeth DeRobertis, MS, RD, CDN, CDE, CPT Director of The Nutrition Center, Scarsdale Medical Group
Achieving Glycemic Control in the Hospital Setting
ADDITIONAL SLIDES FOR ASSIST WITH COMPREHENSION OF LAB CONTENT-MODULE FIVE-DM DENISE TURNER, MS-N.ED, RN, CCRN.
Diabetes Mellitus Part 2 Kathy Martin DNP, RN, CNE.
Insulin order sets – only way to order sustained insulin. Separate versions for 1 st time order and revision.
Special Situations In The Management Of In-Patient Hyperglycemia
Inpatient Diabetes Treatment Goals, Strategies, Safety Amish A. Dangodara, MD, FACP Professor of Medicine Internal Medicine, Hospitalist Program University.
Quality of Life Matters NOT TOO HIGH… NOT TOO LOW… A PLAN FOR OPTIMIZING DIABETES MANAGEMENT IN NURSING HOMES 5. Insulin: Part 1.
New Subcutaneous Insulin Protocol for Type 2 Diabetics
Representative insulin regimens for the treatment of diabetes
Insulins Roland Halil, BScPharm, ACPR, PharmD
Insulin Initiation and Titration
Inpatient Glycemic Management
Representative insulin regimens for the treatment of diabetes
Pharmacy Protocol for Insulin Dosing in the Hospitalized Patient
Pharmacy 515 Acute/Critical Care Pharmacology
Management of diabetes mellitus in hospitalized patients
CASES Inpatient Diabetes.
Representative insulin regimens for the treatment of diabetes
Recommendation In people with clinical cardiovascular disease in whom glycemic targets are not met, a SGLT2 inhibitor with demonstrated cardiovascular.
Representative insulin regimens for the treatment of diabetes
Insulin Delivery Systems Atlanta Diabetes Associates
Insulins Roland Halil, BScPharm, ACPR, PharmD
Alisa Foote SDSU School of Nursing 10/14/11.
Representative insulin regimens for the treatment of diabetes
Insulins Roland Halil, BScPharm, ACPR, PharmD
T1DM: Insulin Initiation
Diabetes.
A: Subcutaneous insulin therapy may be selected as continuation of ambulatory therapy, as new therapy, or as a transition plan from intravenous infusion.
INSULINS Dr.R.Sajjad december INSULINS Dr.R.Sajjad december 2018.
Insulin Delivery Systems Atlanta Diabetes Associates
Inpatient Insulin Management on the Wards
Insulin in Type 2 Diabetes
Presentation transcript:

Inpatient Glycemic Management Shruti Scott, DO, MPH UCI Hospitalist Program July 24, 2013 I am part of the medication safety review committee and hypoglycemia continues to be the leading cause of all medication induced errors. Insulin management amongst our diabetic patients is not easy and its not black and white either. Many factors need to be taken into consideration when you evaluate your diabetic patients: due they have an infection that is causing their blood sugars to be higher then their baseline, are they experiencing nausea and/or vomiting leading to decreased po intake, what is there po intake in the hospital, are they being placed on steroids, etc.

Pharmacokinetics of Insulin Products Rapid (lispro, aspart, glulisine) (Humalog/Novolog/Apidra) Insulin Level Short (regular) Intermediate (NPH) Long (glargine) This slide demonstrates in graphic fashion the peak and duration of action of the various insulin formulations now available. Note that pre-mixed insulin products (i.e., 70/30, etc.) are not shown. Long (detemir) 0 2 4 6 8 10 12 14 16 18 20 22 24 Hours Adapted from Hirsch I. N Engl J Med. 2005;352:174–183.

Case 1 Tom has Type 2 DM, weighs 85 kg and is admitted for diabetic foot ulcer. He takes Metformin 1000mg bid, glipizide 10mg daily at home. He has a normal GFR. His hemoglobin A1c is 10 and his blood sugars since admission have ranged 250-300. How do you manage his DM?

Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: Effect of structured subcutaneous insulin orders and an insulin management algorithm Insulin management algorithm (front) introduced at UCSD in May 2005 (marking the onset of Time Period 3). © This slide is made available for non-commercial use only. Please note that permission may be required for re-use of images in which the copyright is owned by a third party. Journal of Hospital Medicine Volume 4, Issue 1, pages 3-15, 12 JAN 2009 DOI: 10.1002/jhm.391 http://onlinelibrary.wiley.com/doi/10.1002/jhm.391/full#fig2

Case I Answer: Tom weighs 85kg, normal GFR Using standard, 0.4unit/kg = 34 units TDD Lantus 17 units QAM and Lispro 5 units tid before meals Lispro Correctional Learning Points: Hold oral diabetes meds when inpatient (to minimize hypoglycemia and for better glycemic control) DO NOT place diabetic patients only on Correctional Insulin Use weight based method to get accurate insulin requirement Adjust insulin dose for GFR: GFR > 50, no correction GFR 30-50, 20% reduction GFR < 30, 30-50% reduction Its ok to only use Correctional insulin for pre-diabetics or borderline diabetic patients bc they still have enough endogenous insulin production to meet basal needs; or in patients with good glycemic control just on oral medications

Case 1 Learning Points Each order will have 2 or 3 types of insulin: Basal - provides continuous insulin coverage to diminish BS swings Nutritional - treats the anticipated BG increase with meals Correctional - corrects current BS level Nutritional and Correctional coverage should be the same type of insulin (both Lispro or both Regular) Correction insulin is designed to be given independent of nutritional intake. Also remember, studies have shown that the long acting insulins (glargine or levemir) plus the rapid acting insulins (aspart or lispro) mimic physiologic production of insulin better then any other combination (such as NPH, 70/30 combos).

Case 2 Tom has Type 2 DM and was admitted for diabetic foot ulcer. Today is HD3 and his blood sugars have been stable with Lantus 22 units qhs, Humalog 5 units tid and Humalog Correctional. Tomorrow he is having a L foot amputation. How should his insulin regimen be adjusted?

Case 2 Answer Choices Hold Humalog morning dose Cont Humalog morning dose Hold Lantus evening dose Decrease evening dose of Lantus Cont evening Lantus dose Start IVFs (NS, D5 or D10 – does it matter?) Do nothing Page endocrine fellow and ask him/her

Case 2 Answer Hold Humalog nutritional dose while pt is NPO Cont evening Lantus dose (basal insulin) Start IVFs (either D5 or D10) Continue Humalog correctional coverage

Case 2 Learning Points Start D5 or D10 if carb source is interrupted (NPO). The infusion rate will have to take into account the patient’s general condition (CHF, cirrhosis) Do not hold basal insulin if long acting (levemir or glargine) 1 L of D5 1/2NS provides less calories than a small candy bar (170 calories per L) In the Quest NPO Order Set, the number of calories (per liter IVF) is provided for you Remember, Type I DM requires insulin AND carb source (D5 or D10) at all times (even when NPO, to prevent DKA). So if Type I diabetic is NPO, DO NOT hold basal insulin and DO start D5 or D10

Case 3 Tom has Type 2 DM and was admitted for diabetic foot ulcer. Today is HD3 and his blood sugars have been stable with NPH 22 units bid and Regular Correctional. Tomorrow he is having a L foot amputation. How should his insulin regimen be adjusted?

Pharmacokinetics of Insulin Products Rapid (lispro, aspart, glulisine) (Humalog/Novolog/Apidra) Insulin Level Short (regular) Intermediate (NPH) Long (glargine) This slide demonstrates in graphic fashion the peak and duration of action of the various insulin formulations now available. Note that pre-mixed insulin products (i.e., 70/30, etc.) are not shown. Long (detemir) 0 2 4 6 8 10 12 14 16 18 20 22 24 Hours Adapted from Hirsch I. N Engl J Med. 2005;352:174–183.

Case 3 Answer Continue evening NPH dose Half morning NPH dose Start patient on D5 or D10 Continue Correctional insulin Alternatively On admission, change from NPH to Lantus for better glycemic control

Case 4 Tom has Type 2 DM, admitted for diabetic foot ulcer and today is HD3. He is treated with Humalog 5 units tid & Lantus 22 units qhs. Tom has premeal bs of 65 before lunch, does not have any symptoms of hypoglycemia, what should you do?

PRIORITY: DRINK UP! If possible, PO FIRST Treat the SYMPTOMS, not just the number 4 oz Juice/8 oz FF milk = 15 gram carb 15 grams carb can increase BG 30-50mg/dl The 15-15 Rule Treat with 15 grams of carb Recheck in 15 minutes Retreat with 15 grams of carb and recheck every 15 minutes until BG is > 75mg/dl

Things to think about BG within range 70-100mg/dl - DO NOT HOLD INSULIN (basal insulin) - may need dose adjustment Check to see how much patient is eating Has patient been experiencing nausea or vomiting For our patient Tom, if he has few premeal blood glucose readings that are low, need to decrease Lispro nutritional insulin from 5 units tid to 3 units tid

Case 5 Jerry is a 65 yo male who is receiving continuous TPN. He has a h/o DM, weighs 80kg and is on continuous TPN. His blood glucose readings have ranged 250-300, how do you manage his DM and hyperglycemia?

Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: Effect of structured subcutaneous insulin orders and an insulin management algorithm Insulin management algorithm (front) introduced at UCSD in May 2005 (marking the onset of Time Period 3). © This slide is made available for non-commercial use only. Please note that permission may be required for re-use of images in which the copyright is owned by a third party. Journal of Hospital Medicine Volume 4, Issue 1, pages 3-15, 12 JAN 2009 DOI: 10.1002/jhm.391 http://onlinelibrary.wiley.com/doi/10.1002/jhm.391/full#fig2

Case 5 Answer Start Lantus 12 units qhs Start Regular 5 units Q6H Regular Correctional Learning Points For patients who are receiving continuous feeds (either TPN or tube feeds), check blood glucose levels Q6H Regular correctional insulin preferred over Rapid acting (Aspart/Lispro) since patient is not taking food in orally and regular lasts longer then rapid acting Use weight based method. He weighs 80kg and 0.4 units/kg/day = 32 units total daily dose You can do 40% long acting and use 60% as short acti

Inpatient Diabetes Management Pearls Hold all oral DM meds and noninsulin injectable meds on admission If patient is on insulin, give them 2/3 of their home dose (basal and nutritional) as they don’t eat the same foods in the hospital vs at home Always account for renal function When NPO, always give carb source (D5@100 or 125 or D10@50 depending on overall fluid state) Pt should be on same insulin for nutritional and correctional

Diabetic Goals Avoid Hypoglycemia Avoid Severe Hyperglycemia 3. Adequate Nutrition 4. Pre-discharge education harmful due to the effects of counter-regulatory hormones, especially catecholamines, which may possibly induce arrhythmias and other cardiac events. Studies show increased overall mortality with patients who have at least one hypo episode in the hospital even after discharge. 2) Immune system impaired, Volume depletion, Electrolyte abnormalities through osmotic diuresis 3) For the majority of critically ill patients, the American Diabetes Association and the American College of Endocrinology recommend a blood glucose target of 140 to 180 mg/dL Oral agents should never be administered to patients who are not eating.